Aily Labs, the creator of a mobile-first AI Decision Intelligence platform, has secured an $80 million funding round.
The investment was led by FPV Ventures, with notable participation from existing investor Insight Partners and financial giant J.P. Morgan.
The capital is earmarked to accelerate global expansion and further develop Aily's autonomous AI agent ecosystem, which is already used by Fortune 500 companies.
From Pharma Exec to AI Founder
Aily Labs was founded in 2020 by Bianca Anghelina, a former pharmaceutical executive who led digital finance and AI transformation at Novartis.
Frustrated by the gap between collecting massive amounts of enterprise data and making fast, effective decisions, she created Aily.
The platform is a mobile-first app designed to give every employee, from the frontline to the C-suite, actionable insights in real-time, moving from complex data to clear business impact in less than two weeks.
Aily Labs Funding History
| Round | Amount | Date | Lead Investors | Total Raised (est.) |
|---|---|---|---|---|
| Growth Round | $80M | Nov 2025 | FPV Ventures | ~$100M+ |
| Series A | €19M (~$21M) | Aug 2023 | Insight Partners | ~$21M |
Analyzing the $80M Investment
The significant investment in Aily Labs signals a clear market shift. Enterprises are no longer satisfied with dashboards and analytics; they demand AI that recommends and executes decisions.
Pegah Ebrahimi, Co-founder at FPV Ventures, highlighted this pain point, noting that CEOs often struggle to get real business value from their AI spending.
Aily Labs addresses this directly by delivering measurable P&L impact.
The new funding will be used to scale its go-to-market teams, enhance its proprietary Decision Intelligence LLM, and advance its “Super Agent” that orchestrates autonomous actions across an organization.
Company Overview
| Parameter | Details |
|---|---|
| Founded | 2020 |
| Headquarters | New York, with global operations |
| Founder & CEO | Bianca Anghelina |
| Market Focus | AI-native Decision Intelligence Platform for enterprises |
| Target Verticals | Pharmaceuticals, Retail, Consumer Goods, Finance, Supply Chain |
| Key Feature | Mobile-first AI agents that recommend and execute decisions |
| AICurator Rating | 9.0/10 – Addresses a critical enterprise pain point with a clear ROI. Strong founder-market fit and backing from top-tier investors. Faces the challenge of scaling complex AI safely within large organizations. |
Key Deal Facts
Who were the main investors in this round?
The round was led by FPV Ventures, with participation from Insight Partners and J.P. Morgan.
What will the new capital be used for?
The funds will accelerate global expansion, advance the autonomous AI agent ecosystem, and enhance Aily's proprietary Decision Intelligence LLM.
What makes Aily's approach different?
Its mobile-first platform provides autonomous agents that don't just offer insights but can also execute decisions, delivering measurable business results in weeks.
The Road to Autonomous Enterprise
Aily Labs is positioned to become a central nervous system for major corporations. Its immediate path involves deeper penetration into key verticals like pharmaceuticals, retail, and consumer goods.
The primary challenge will be navigating the complexities of large-scale enterprise adoption while proving that its autonomous agents can consistently drive financial performance.
If successful, Aily Labs could set a new standard for how global companies operate.
Connect With Aily Labs
| Platform | Link |
|---|---|
| Website | ailylabs.com |
| linkedin.com/company/ailylabs | |
| X (Twitter) | @AilyLabs |
| Location | New York, NY (U.S. Hub) |
